The Burden of Osteoarthritis: Clinical and Quality-of-Life Issue with rofecoxib. Osteoarthritis Cartilage. 2004: 12(11): 36. Jones JG, Leighton F. Comparison of WOMAC th SF-36 for OA of the knee or hip. Ann Rheum Dis. 32. Salaffi F Carotti M, Stancati A, Grassi W. ated quality of life in older adults with sy 37. Liang M, Schurman DJ, Fries J. A patient-admin essment. clir vith matched healthy controls. Aging Clin Exp Res 2005;17(4):255-263. Orthop Relat Res. 1978: 131: 123-129. 33. Keller SD, Ware JE Jr, Hatoum HT, Kong SX. The 8. Stratford PW, Kennedy DM. Performance mea- SF-36 Arthritis-Specific Health Index (ASHI): Il. Tests ures were necessary to obtain plete pic- of validity in four clinical trials. Med Care. 1999; 37(5 uppl): Ms51-MS60 2006:59(2):160-167 4. Ware JE Jr, Keller SD, Hatoum HT, Kong SX. 9. Insall JN. Dorr LD, Scott RD, Scott WN. Rationale of The SF-36 Arthritis-Specific Health Index(ASHI the Knee society clinical rating system. Clin Orthop Relat Res.1989248:13-14. 35. Stratford PW, Kennedy DM, Woodhouse LJ, Spadoni erformance measures provide assessments of pain GF Measurement properties of the WOMAC LK 3.1 ion in people with advanced osteoarthritis of pain scale. Osteoarthritis Cartilage. 2007: 15(3): 266-272. the hip or knee. Phys Ther. 2006: 86(11): 1489-1496. VOL 15. NO. 8 THE AMERICAMOUR&L F MANAGED CAREThe Burden of Osteoarthritis: Clinical and Quality-of-Life Issues VOL. 15, No. 8 n The American Journal of Managed Care n S229 with rofecoxib. Osteoarthritis Cartilage. 2004;12(11): 912-916. 32. Salaffi F, Carotti M, Stancati A, Grassi W. Health￾related quality of life in older adults with symp￾tomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res. 2005;17(4):255-263. 33. Keller SD, Ware JE Jr, Hatoum HT, Kong SX. The SF-36 Arthritis-Specific Health Index (ASHI): II. Tests of validity in four clinical trials. Med Care. 1999;37(5 suppl):MS51-MS60. 34. Ware JE Jr, Keller SD, Hatoum HT, Kong SX. The SF-36 Arthritis-Specific Health Index (ASHI): I. Development and cross-validation of scoring algo￾rithms. Med Care. 1999;37(5 suppl):MS40-MS50. 35. Stratford PW, Kennedy DM, Woodhouse LJ, Spadoni GF. Measurement properties of the WOMAC LK 3.1 pain scale. Osteoarthritis Cartilage. 2007;15(3):266-272. 36. Jones JG, Leighton F. Comparison of WOMAC with SF-36 for OA of the knee or hip. Ann Rheum Dis. 2002;61(2):182-183. 37. Liang M, Schurman DJ, Fries J. A patient-admin￾istered questionnaire for arthritis assessment. Clin Orthop Relat Res. 1978;131:123-129. 38. Stratford PW, Kennedy DM. Performance mea￾sures were necessary to obtain a complete pic￾ture of osteoarthritic patients. J Clin Epidemiol. 2006;59(2):160-167. 39. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989;248:13-14. 40. Stratford PW, Kennedy DM, Woodhouse LJ. Performance measures provide assessments of pain and function in people with advanced osteoarthritis of the hip or knee. Phys Ther. 2006;86(11):1489-1496. 第 138 页